肺塞栓症治療薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00014950
  • Category : Life Sciences
  • No. of Pages : 150
今すぐ購入

市場紹介 肺塞栓症は、血液が凝固し、その凝固が肺の肺動脈を閉塞する状態です。この血栓はさらに深部静脈血栓症を引き起こす可能性があります。重度の血液凝固により生命を脅かす状態ですが、適切な治療により病気の重症度を軽減できます。肺塞栓症の恐ろしい症状には、胸痛、息切れ、長期にわたる咳、発熱などが含まれます。経口経路と非経口経路の両方で肺塞栓症を治療するために利用できる治療選択肢は数多くあります。 市場ダイナミクス肺塞栓症治療薬市場の成長ドライバーには、肺塞栓症を治療するための多くの治療選択肢の利用可能性、強力な償還政策の利用可能性、肺塞栓症に関連するリスク要因の増大が含まれており、予測中に市場の成長を押し上げようとしています期間。しかし、肺塞栓症治療の高額な費用が市場の抑制要因となっています。 市場範囲 「肺塞栓症治療学」は、世界市場の傾向分析に特に焦点を当てた、製薬業界の専門的で詳細な調査です。レポートは、タイプ、アプリケーションによる詳細な市場セグメンテーションとともに、肺塞栓症治療薬市場の概要を提供することを目的としています。肺塞栓症治療薬市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、肺塞栓症治療市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション 肺塞栓症治療薬市場は、タイプ、アプリケーションに基づいて分割されています。種類に基づいて、経口および非経口などの薬物投与経路に分類されます。そして、アプリケーションに基づいて、病院、外来手術センター、研究機関に分類されます。 このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいて、肺塞栓症治療薬市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米。各地域ごとの肺塞栓症治療薬市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、需要と供給の両方の側面から肺塞栓症治療薬市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、中南米は、これらの地域の肺塞栓症治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。 市場関係者 レポートは、有機的および無機的な成長戦略として肺塞栓症治療市場の主要な発展をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。肺塞栓症治療薬市場の市場プレーヤーは、世界市場での肺塞栓症治療薬市場の需要の高まりに伴い、将来的に有利な成長の機会があると予想されています。以下は、肺塞栓症治療市場に従事するいくつかの企業のリストです。レポートには、SWOT分析と市場戦略とともに、肺塞栓症治療市場の主要プレーヤーのプロフィールも含まれています。さらに、このレポートは、企業概要、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供する業界の主要企業に焦点を当てています。
    • 第一三共株式会社 • Boehringer Ingelheim International GmbH • Johnson and Johnson Services Inc • Genentech • Insera Therapeutics, Inc • Bristol-Myers Squibb Co. •  F. Hoffman -La Roche Ltd. • Roche • Fresenius Kabi USA • Pfizer Inc
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供しています。 。
  • 過去2年間の分析、基準年、CAGRによる予測(7年間)
  • PEST分析とSWOT分析
  • 市場規模価値/数量 - 世界、地域、国
  • 業界と競争環境
  • Excel データセット
pulmonary-embolism-therapeutics-market-report-deliverables-img1
pulmonary-embolism-therapeutics-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

よくある質問


What is the expected CAGR of the Pulmonary Embolism Therapeutics Market?

The Pulmonary Embolism Therapeutics Market is estimated to witness a CAGR of 4% from 2025 to 2031.

What are the driving factors impacting the Pulmonary Embolism Therapeutics Market?

The major factors driving the Pulmonary Embolism Therapeutics Market are Rising Incidence of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT), Advancements in Pharmacological Treatment Options, and Increasing Focus on Early Diagnosis and Screening.

What are the future trends of the Pulmonary Embolism Therapeutics Market?

Future trends in the Pulmonary Embolism Therapeutics Market are Personalized Medicine in Pulmonary Embolism Treatment, Minimally Invasive Treatments for Pulmonary Embolism, and Growing Focus on Acute Pulmonary Embolism Treatments.

Which are the leading players in the Pulmonary Embolism Therapeutics Market?

Some of the players operating in the market are Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Johnson and Johnson Services Inc, Genentech, Insera Therapeutics, Inc, Bristol- Myers Squibb Co., F. Hoffman -La Roche Ltd., Roche, Fresenius Kabi USA, Pfizer Inc.

What are the deliverable formats of the Pulmonary Embolism Therapeutics Market report?

The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.

What are the options available for the customization of this report?

Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Daiichi Sankyo Co. Ltd.
2. Boehringer Ingelheim International GmbH
3. Johnson and Johnson Services Inc
4. Genentech
5. Insera Therapeutics, Inc
6. Bristol- Myers Squibb Co.
7. F.Hoffmann-La Roche Ltd
8. Roche
9. Fresenius Kabi USA
10. Pfizer Inc
pulmonary-embolism-therapeutics-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.